Takeda Pharma A/S: public contracts won without a rival in Denmark: 8 uncontested awards; 25% of its awards; 0 without a competition; 8 single bid.
Assay record ASY-DK-0LI50CE1FQ · Cite as: Assay Systems, “Takeda Pharma A/S: public contracts won without a rival in Denmark”, https://assay-systems.com/register/dk/uncontested/s/takeda-pharma-a-s/
Takeda Pharma A/S won 8 of its 32 public contract awards in Denmark without a rival from 2024-05-16 to 2026-09-30: 0 without a competition and 8 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Amgros I/S with 8.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
Amgros I/S gave Takeda Pharma A/S 32 awards: 0 without a competition, 8 after a competition with a single bid. First 2024-05-16, latest 2026-09-30.
| Date | Buyer | How | Stated reason |
|---|---|---|---|
| 2025-12-04 | Amgros I/S 805300-2025 | Single bid open | — |
| 2025-10-15 | Amgros I/S 676086-2025 | Single bid open | — |
| 2025-10-14 | Amgros I/S 674432-2025 | Single bid open | — |
| 2025-05-13 | Amgros I/S 305388-2025 | Single bid open | — |
| 2025-02-19 | Amgros I/S 111927-2025 | Single bid open | — |
| 2024-10-25 | Amgros I/S 650475-2024 | Single bid open | — |
Every uncontested award in Denmark · All countries · Takeda Pharma A/S in the register
Source: Tenders Electronic Daily (TED), Publications Office of the European Union, contract award notices. Awards are matched to their buyer and supplier as published. Values in these notices often state a framework ceiling rather than a contract amount, so awards are counted, not summed. Updated 17 October 2026.